 |
doxorubicin with pluronics F-127 and L-61 |
|---|---|
| Trade Name | |
| Orphan Indication | Stomach Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2008-02-20 00:00:00 |
| Sponsor | Supratek Pharma, Inc.;6100 Royalmount Avenue, Montreal;Quebec H4P 2R2 |
Related Access Program